Deep-Dive Due Diligence AI Generated Report on Amprius Technologies, Inc. (AMPX)
Welcome to ScanScor. What you're reading is not just a stock summary -- it's a real-time, AI-generated due diligence session crafted from live news, financial data, insider trading activity, SEC filings, and live market momentum.
These reports are generated using OpenAI's GPT-based analysis engine, guided by tightly structured prompts and expert-level data ingestion. Every insight below was assembled to help you understand the forces behind today's market movers.
Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.
AMPX_OUT_1 [2025-03-21 11:38:06 -0400] 2086 Bytes | 588 tokens | Cum: 588 tkns (7.35% of 8k)
==========================================================================
You're the expert here today. So, I pulled together a bunch of data for you to look over real fast. I'm looking at high-performance stocks today and Amprius Technologies (AMPX) hit my radar screen, up to 2.755 from a prev close of 2.31 Do you think its got more juice or is it lacking potential? It's 11:38:05 AM on Fri Mar 21, 2025 -0400 and I have to decide: buy or sell!
Here's the first list of news for Amprius Technologies:
C1 - Mar-20-25 10:53PM - Amprius targets 2025 growth with $16M new orders and global manufacturing expansion
C2 - Mar-20-25 10:53PM 10:53PM - Amprius Technologies, Inc. (AMPX) Q4 2024 Earnings Call Transcript
C3 - Mar-20-25 10:53PM 06:50PM - Amprius Technologies (AMPX) Reports Q4 Loss, Tops Revenue Estimates
C4 - Mar-20-25 10:53PM 04:05PM - Amprius Technologies Reports Fourth Quarter and Full Year 2024 Business and Financial Results
C5 - Mar-06-25 04:05PM - Amprius Technologies Announces Date for Fourth Quarter and Full Year 2024 Results and Business Updates
C6 - Mar-06-25 04:05PM 08:30AM - Amprius Ships New High-Performance 6.3Ah Silicon Anode Cylindrical Cell to Fortune 500 Company
C7 - Mar-04-25 04:05PM - Amprius Technologies Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results
C8 - Mar-03-25 08:30AM - Amprius Sets March 2025 Events Schedule
ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Amprius Technologies (AMPX)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".
AMPX_IN_2 [2025-03-21 11:38:06 -0400] 2 Bytes | 2 tokens | Cum: 590 tkns (7.38% of 8k)
==========================================================================
C3
AMPX_OUT_3 [2025-03-21 11:38:08 -0400] 1038 Bytes | 274 tokens | Cum: 864 tkns (10.80% of 8k)
==========================================================================
Showing C3 (chunk 1 of 9): C3:
**Amprius Technologies (AMPX) Reports Q4 Loss, Tops Revenue Estimates**
Date: Mar-20-25 10:53PM 06:50PM
Source: (Zacks)
URL: https://www.zacks.com/stock/news/2433154/amprius-technologies-ampx-reports-q4-loss-tops-revenue-estimates?cid=CS-FINVIZ-FT-tale_of_the_tape|yseop_template_4-2433154
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies. In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept ourPrivacy PolicyandTerms of Service, revis
-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)
AMPX_IN_4 [2025-03-21 11:38:09 -0400] 3 Bytes | 2 tokens | Cum: 866 tkns (10.82% of 8k)
==========================================================================
NEX
AMPX_OUT_5 [2025-03-21 11:38:10 -0400] 901 Bytes | 278 tokens | Cum: 1144 tkns (14.30% of 8k)
==========================================================================
We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.
A1 - 2025-03-21T14:00:28Z - Demystifying Amprius Technologies: Insights From 4 Analyst Reviews - Amprius Technologies (NYSE:AMPX...
A2 - 2025-03-21T12:10:17Z - 12 Industrials Stocks Moving In Friday's Pre-Market Session - DSS (AMEX:DSS), Amprius Technologies (...
A3 - 2025-03-21T02:53:06Z - Amprius Technologies, Inc. (AMPX) Q4 2024 Earnings Call Transcript...
A4 - 2025-03-20T23:53:00Z - Amprius Technologies (AMPX) Reports Q4 Loss, Tops Revenue Estimates...
A5 - 2025-03-20T22:20:33Z - Amprius: Q4 Earnings Snapshot...
Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.
AMPX_IN_6 [2025-03-21 11:38:10 -0400] 2 Bytes | 2 tokens | Cum: 1146 tkns (14.32% of 8k)
==========================================================================
A1
AMPX_OUT_7 [2025-03-21 11:38:11 -0400] 1038 Bytes | 325 tokens | Cum: 1471 tkns (18.39% of 8k)
==========================================================================
Showing A1 (chunk 1 of 7): A1:
**Demystifying Amprius Technologies: Insights From 4 Analyst Reviews - Amprius Technologies (NYSE:AMPX)**Date: 2025-03-21Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/analyst-ratings/25/03/44436758/demystifying-amprius-technologies-insights-from-4-analyst-reviewsAmprius Technologies AMPX underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 2 0 0 0 Last 30D 2 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 1 0 0 0 3M Ago 0 1 0 0 0
Insights from analysts' 12-month price targets are revealed, presenting an average target of $9.0, a hi
-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)
AMPX_IN_8 [2025-03-21 11:38:12 -0400] 3 Bytes | 2 tokens | Cum: 1473 tkns (18.41% of 8k)
==========================================================================
MOR
AMPX_OUT_9 [2025-03-21 11:38:13 -0400] 1038 Bytes | 247 tokens | Cum: 1720 tkns (21.50% of 8k)
==========================================================================
Showing A1 (chunk 2 of 7): gh estimate of $10.00, and a low estimate of $6.00. Observing a 42.18% increase, the current average has risen from the previous average price target of $6.33.
Diving into Analyst Ratings: An In-Depth Exploration
A clear picture of Amprius Technologies's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Christopher Souther B. Riley Securities Raises Buy $6.00 $5.00 Amit Dayal HC Wainwright & Co. Maintains Buy $10.00 $10.00 Derek Soderberg Cantor Fitzgerald Announces Overweight $10.00 - Ted Jackson Northland Capital Markets Raises Outperform $10.00 $4.00 Key Insights: Action Taken: In response to dynamic market conditions and company performance, a
-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)
AMPX_IN_10 [2025-03-21 11:38:13 -0400] 3 Bytes | 2 tokens | Cum: 1722 tkns (21.52% of 8k)
==========================================================================
NEX
AMPX_OUT_11 [2025-03-21 11:38:14 -0400] 905 Bytes | 288 tokens | Cum: 2010 tkns (25.12% of 8k)
==========================================================================
This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!
B1 - 2025-02-04T13:08:00Z - Top 3 High-Momentum Companies Analysts Are Still Bullish On
B2 - 2024-11-01T19:52:00Z - Record Investments Needed in Renewable Tech and Mining to Hit Global Emission Targets
B3 - 2024-05-09T21:30:03Z - Amprius Technologies (AMPX) Reports Q1 Loss, Tops Revenue Estimates
B4 - 2024-05-06T14:00:08Z - Analysts Estimate Bitfarms Ltd. (BITF) to Report a Decline in Earnings: What to Look Out for
B5 - 2024-05-02T14:00:58Z - Amprius Technologies (AMPX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
B6 - 2024-03-19T12:50:00Z - Should You Buy Amprius Technologies (AMPX) Ahead of Earnings?
Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.
AMPX_IN_12 [2025-03-21 11:38:14 -0400] 2 Bytes | 2 tokens | Cum: 2012 tkns (25.15% of 8k)
==========================================================================
B1
AMPX_OUT_13 [2025-03-21 11:38:17 -0400] 597 Bytes | 147 tokens | Cum: 2159 tkns (26.99% of 8k)
==========================================================================
Showing B1 (chunk 1 of 1): B1:
**Top 3 High-Momentum Companies Analysts Are Still Bullish On**Date: Unknown DateSource: Unknown SourceURL: https://www.investing.com/analysis/top-3-highmomentum-companies-analysts-are-still-bullish-on-200656960Three companies with recent stock rallies that analysts remain bullish on are Compass Therapeutics, Amprius Technologies, and Allot Communications. Analysts see significant upside potential in these momentum stocks despite their recent gains.
-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)
AMPX_IN_14 [2025-03-21 11:38:17 -0400] 237 Bytes | 43 tokens | Cum: 2202 tkns (27.52% of 8k)
==========================================================================
Compass Therapeutics, Amprius Technologies, and Allot Communications are three high-momentum companies that analysts remain bullish on, despite their recent stock rallies. They see significant potential for further gains in these stocks.
AMPX_OUT_15 [2025-03-21 11:38:19 -0400] 1093 Bytes | 278 tokens | Cum: 2480 tkns (31.00% of 8k)
==========================================================================
This is our list of SEC filings.
If empty, the search returned no recent filings.
S1 - 2025-03-20 10-K Item 7. Mgts Discussion and Analysis of Fin Cond and Results of Oper
You should read the following discussion and analysis of our financial condition and results of operations together with our audited financial statements and the related notes included...
S2 - 2025-03-20 8-K Item 2.02 Results of Oper and Fin Cond.
On March 20, 2025, Amprius Technologies, Inc. (the Company) announced its business and financial results for its fourth fiscal quarter and full year ended December 31, 2024. A copy of the Companys Letter to Shareholders i...
S5 - 2025-03-04 8-K Item 2.02 Results of Oper and Fin Cond.
On March 4, 2025, Amprius Technologies, Inc. (the Company) issued a press release containing certain preliminary financial information for the quarter and full year ended December 31, 2024. A copy of the press release con...
Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.
AMPX_IN_16 [2025-03-21 11:38:19 -0400] 2 Bytes | 2 tokens | Cum: 2482 tkns (31.03% of 8k)
==========================================================================
S1
AMPX_OUT_17 [2025-03-21 11:38:21 -0400] 1038 Bytes | 206 tokens | Cum: 2688 tkns (33.60% of 8k)
==========================================================================
Showing S1 (chunk 1 of 6): S1:
Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations
You should read the following discussion and analysis of our financial condition and results of operations together with our audited financial statements and the related notes included elsewhere in this Annual Report on Form 10-K. Some of the information contained in this discussion and analysis or set forth elsewhere in this Form 10-K, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in the sections titled Risk Factors and Cautionary Note Regarding Forward-Looking Statements in this Form 10-K, our actual results could differ materially from the results described in or implied by the forward-looking state
-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)
AMPX_IN_18 [2025-03-21 11:38:21 -0400] 3 Bytes | 2 tokens | Cum: 2690 tkns (33.62% of 8k)
==========================================================================
NEX
AMPX_OUT_19 [2025-03-21 11:38:39 -0400] 6026 Bytes | 1707 tokens | Cum: 4397 tkns (54.96% of 8k)
==========================================================================
This is our set of metrics.
Please analyze the numbers.
+-------------------+----------------------+-----------------------+-------------------------+------------------------+------------------------+
| Volume: 4,896,618 | SMA50: -7.95% | Market Cap: 295.04M | Option/Short: Yes / Yes | Sales past 5Y: 41.21% | Sales Surprise: 27.56% |
+-------------------+----------------------+-----------------------+-------------------------+------------------------+------------------------+
| Avg Volume: 3.83M | SMA200: 46.86% | Shs Outstand: 111.34M | Short Float: 5.34% | Employees: 88 | EPS Surprise: 5.39% |
+-------------------+----------------------+-----------------------+-------------------------+------------------------+------------------------+
| Rel Volume: 3.96 | Perf Week: 30.79% | Shs Float: 77.22M | Short Ratio: 1.08 | Debt/Eq: 0.67 | P/E: - |
+-------------------+----------------------+-----------------------+-------------------------+------------------------+------------------------+
| RSI (14): 56.30 | Perf Month: -19.63% | Inst Own: 14.62% | Short Interest: 4.13M | Sales Y/Y TTM: 196.22% | Earnings: Mar 20 AMC |
+-------------------+----------------------+-----------------------+-------------------------+------------------------+------------------------+
| ATR (14): 0.29 | Perf Quarter: 51.60% | Insider Own: 30.17% | Beta: 2.45 | ROE: -71.81% | |
+-------------------+----------------------+-----------------------+-------------------------+------------------------+------------------------+
| SMA20: 19.25% | Index: RUT | Insider Trans: -0.90% | Sales Q/Q: 180.74% | ROI: -47.93% | |
+-------------------+----------------------+-----------------------+-------------------------+------------------------+------------------------+
The next section covers any insider trading.
If this section may be blank due to no recent filings.
Inside Trans: Amprius Technologies, Inc. (AMPX) by Stefan Constantin Ionel (Chief Technology Officer) on 2025-03-14
- Common stock: 3471 shares at $0.98 (D)
- Stock Option (right to buy): 3471 shares at $0 (D)
Inside Trans: Amprius Technologies, Inc. (AMPX) by Bornstein Jonathan (President of Amprius Lab) on 2025-03-10
- Common stock: 3471 shares at $0.98 (D)
- Stock Option (right to buy): 3471 shares at $0 (D)
Inside Trans: Amprius Technologies, Inc. (AMPX) by Sun Kang (Chief Executive Officer) on 2025-02-21
- Common stock: 34353 shares at $3.1332 (D) Footnote: This transaction was effected pursuant to non-discretionary, sell-to-cover arrangements mandated by the issuer to fund tax withholding obligations in connection with the vesting of restricted stock units.
Inside Trans: Amprius Technologies, Inc. (AMPX) by Wallach Sandra (Chief Financial Officer) on 2025-02-21
- Common stock: 18142 shares at $3.1332 (D) Footnote: This transaction was effected pursuant to non-discretionary, sell-to-cover arrangements mandated by the issuer to fund tax withholding obligations in connection with the vesting of restricted stock units.
Inside Trans: Amprius Technologies, Inc. (AMPX) by Stefan Constantin Ionel (Chief Technology Officer) on 2025-02-21
- Common stock: 9066 shares at $3.1332 (D)
Inside Trans: Amprius Technologies, Inc. (AMPX) by Bornstein Jonathan (President of Amprius Lab) on 2025-02-21
- Common stock: 13527 shares at $3.1332 (D) Footnote: This transaction was effected pursuant to non-discretionary, sell-to-cover arrangements mandated by the issuer to fund tax withholding obligations in connection with the vesting of restricted stock units.
[Company Financial Summary]
[Company Details]
Name: Amprius Technologies, Inc.
Market Cap: 257638824.99
Shares Outstanding: 110574603
Sector: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES
[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 7855000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -10850000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A
[Price Metrics - Last 30 Days]
Latest Close: 2.711
Average Volume: 3083405.22
30-Day High: 3.36
30-Day Low: 1.78
[Detailed Financials: Q3 2024]
- Total Assets: $104,207,000.0
- Total Liabilities: $48,208,000.0
- Total Equity: $55,999,000.0
- Current Assets: $44,940,000.0
- Current Liabilities: $13,000,000.0
[Income Statement: Q3 2024]
- Revenue: $7,855,000.00
- Net Income: $-10,850,000.0
- Operating Income: $-11,253,000.0
- Earnings Per Share (EPS): -0.1
[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $-11,402,000.0
[Detailed Financials: Q2 2024]
- Total Assets: $112,759,000.0
- Total Liabilities: $47,630,000.0
- Total Equity: $65,129,000.0
- Current Assets: $53,043,000.0
- Current Liabilities: $12,826,000.0
[Income Statement: Q2 2024]
- Revenue: $3,345,000.00
- Net Income: $-12,517,000.0
- Operating Income: $-12,932,000.0
- Earnings Per Share (EPS): -0.13
[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $7,402,000.0
==== END OF FINANCIAL REPORT ====
You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.
Now, complete this report with the following:
1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]
1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE
AMPX_IN_20 [2025-03-21 11:38:39 -0400] 1229 Bytes | 288 tokens | Cum: 4685 tkns (58.56% of 8k)
==========================================================================
1) Brief Summary: Amprius Technologies, Inc. (AMPX) demonstrates significant growth potential with a strong sales figure of 41.21% over the past 5 years and a massive 196.22% sales growth year over year. The company is highly volatile with a beta of 2.45 and has a short interest of 5.34%. Insiders own a good chunk of the company at 30.17%, which indicates confidence in the company's future. However, the company's debt to equity ratio of 0.67 and negative return on equity of -71.81% raises concerns about the company's financial health.
2) MARKET_SCORE: Given the financial metrics presented, the company's high sales growth and insider ownership indicate potential for growth. However, the high debt and negative return on equity, as well as the company's volatility, suggest significant risk. Therefore, I estimate a 65% likelihood of upward moves. MARKET_SCORE[65].
3) PRICE_TARGET: Considering the company's growth potential and risk factors, I estimate a modest price increase of 20%. Therefore, if the current price is $2.711, a 20% increase would result in a price target of approximately $3.25. PRICE_TARGET[$3.25].
4) AI_RPT_HEADLINE: "Amprius Technologies: High Growth Potential Amidst Financial Health Concerns"
AMPX_OUT_21 [2025-03-21 11:38:41 -0400] 676 Bytes | 167 tokens | Cum: 4852 tkns (60.65% of 8k)
==========================================================================
Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)
AMPX_IN_22 [2025-03-21 11:38:41 -0400] 94 Bytes | 28 tokens | Cum: 4880 tkns (61.00% of 8k)
==========================================================================
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
AMPX_IN_23 [2025-03-21 11:38:41 -0400] 126 Bytes | 29 tokens | Cum: 4909 tkns (61.36% of 8k)
==========================================================================
====================================
[2025-03-21 08:38:41] # Analysis Completed
Elapsed Time: 36.78 seconds